The current status of curettage and electrodesiccation

Goldman, Glenn D.

doi:10.1016/s0733-8635(02)00022-0

Cited by 50 publications

(30 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…3 Although excellent cure rates can be achieved by experienced clinicians for selected low-risk tumors, particularly on the trunk and extremities, the results are considered highly operator and location dependent. 58,59 Moreover, C&E may be associated with a longer healing time and inferior cosmetic outcome compared with standard excision, and it is best avoided in cosmetically sensitive areas. 44 …”

Section: Curretage and Electrodessicationmentioning

confidence: 99%

Guidelines of care for the management of basal cell carcinoma

Baum¹,

Bordeaux²,

Brown³

et al. 2018

Journal of the American Academy of Dermatology

315

219

View full text Add to dashboard Cite

Basal cell carcinoma (BCC) is the most common form of human cancer, with a continually increasing annual incidence in the United States. When diagnosed early, the majority of BCCs are readily treated with office-based therapy, which is highly curative. In these evidence-based guidelines of care, we provide recommendations for the management of patients with BCC, as well as an in-depth review of the best available literature in support of these recommendations. We discuss biopsy techniques for a clinically suspicious lesion and offer recommendations for the histopathologic interpretation of BCC. In the absence of a formal staging system, the best available stratification based on risk for recurrence is reviewed. With regard to treatment, we provide recommendations on treatment modalities along a broad therapeutic spectrum, ranging from topical agents and superficially destructive modalities to surgical techniques and systemic therapy. Finally, we review the available literature and provide recommendations on prevention and the most appropriate follow-up for patients in whom BCC has been diagnosed. ( J Am Acad Dermatol

show abstract

Section: Curretage and Electrodessicationmentioning

confidence: 99%

Guidelines of care for the management of basal cell carcinoma

Baum¹,

Bordeaux²,

Brown³

et al. 2018

Journal of the American Academy of Dermatology

315

219

View full text Add to dashboard Cite

show abstract

“…Tumor extension into the subcutaneous fat requires a more formal surgical resection. Goldman describes a lower recurrence rate on the trunk and extremities secondary to a thicker dermis allowing better “feel” during curettage [56]. Werlinger et al describe its use for cSCC, with 2 cases of recurrence after treatment of 56 patients compared to no recurrences with surgical excision.…”

Section: Treatmentmentioning

confidence: 99%

Cutaneous Squamous Cell Carcinoma of the Head and Neck

Gurudutt

Genden²

2011

Journal of Skin Cancer

View full text Add to dashboard Cite

Cutaneous squamous cell carcinoma of the head and neck is an epidemic that reaches all parts of the world. Making the diagnosis relies on the acumen of the clinician and pathologist. Various pathologic subtypes exist and differ in histology and prognosis. High-risk tumors need aggressive treatment and vigilant surveillance to monitor for recurrence. Large tumors, deep tissue invasion, perineural involvement, recurrence, location in high-risk areas, and immunosuppression are implicated in worsening prognosis. Surgery is the mainstay of treatment with adjuvant radiation therapy as needed for aggressive tumors; however, other modalities are potentially useful for low-risk lesions. The use of Mohs surgery has become increasingly useful and has shown high success rates. Involvement of parotid and neck lymph nodes significantly affects outcomes and the physician should be comfortable with management of this complex disease. This paper examines the diagnosis, pathology, clinical course, and treatment options for cutaneous squamous cell carcinoma of the head and neck.

show abstract

“…ED&C should be used with caution in lesions with the potential for deep follicular extension because there is a higher risk of recurrence. 15 Basal cell carcinoma Perhaps the most common and significant indication of electrosurgery is ED&C for the treatment of BCC. The success rate of ED&C is highly operatordependent because adequate treatment requires that the clinician possess the skill to detect subclinical tumor extension by its physical consistency using the curette.…”

Section: Electrodesiccation and Curettagementioning

confidence: 99%

“…Undermined epidermis at the periphery of the curettage site may be trimmed using scissors. 15 One study summarized all studies of BCC treated by ED&C since 1947 and reported a weighted average 5-year recurrence rate of approximately 8%. 16 Another study reported determinants of 5-year recurrence rates of 2314 primary BCCs treated by ED&C between 1955 and 1982.…”

Section: Electrodesiccation and Curettagementioning

confidence: 99%

“…ED&C thus provides excellent treatment and cosmetic outcomes for superficial and nodular BCC, although these depend significantly on anatomic location and lesion size. 15,17 Electrocoagulation Outcomes relevant to electrocoagulation include hemostasis and, rarely, surgical incision. Hemostasis should be reserved for vessels < 1 mm in diameter; larger vessels or arterioles have a greater chance of delayed bleeding and should be ligated with a dissolvable suture.…”

Section: Malignant Lesionsmentioning

confidence: 99%

See 1 more Smart Citation